The paradox of bleeding and thrombosis in thrombocythemia: Is von Willebrand factor the link?

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 4, 1997, Pages 385-389

  Van Genderen, Perry J J ^a   Leenknegt, Henriette ^a   Michiels, Jan J ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Goodheart Institute   (Netherlands)

Author keywords

Aspirin; Bleeding; Essential thrombocythemia; Myeloproliferative disorders; Platelets; Thrombosis; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HEMOSTASIS; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTHEMIA; THROMBOSIS;

EID: 0030872008     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996113     Document Type: Review

References (15)

1. Van Genderen PJJ, JJ Michiels: Primary thrombocythemia: Diagnosis, clinical manifestations and management. Ann Hematol 67: 57-62, 1993.
2. Schafer AI: Essential thrombocythemia. Prog Hemostas Thromb 10:69-96, 1991.
3. Van Genderen PJJ, H Leenknegt, JJ Michiels, U Budde: Acquired von Willebrand disease in myeloproliferative disorders. Leuk Lymphoma 22(Suppl 1):79-82, 1996.
4. Budde U, R Scharf, P Franke, K Hartmann-Budde, J Dent, ZM Ruggeri: Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 82: 1749-1757, 1993.
5. Van Genderen PJJ, JJ Michiels, SCAPM van der Poel- van de Luytgaarde, HHDM van Vliet: Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count. Ann Hematol 69:81-84, 1994.
6. Van Genderen PJJ, U Budde, JJ Michiels, R van Strik, HHDM van Vliet: The reduction of large von Willebrand factor multimers in plasma in essential thrombocythemia is related to the platelet count. Br J Haematol 93:962-965, 1996.
7. Lopez-Fernandez MF, C Lopez-Berges, R Martin, A Pardo, FJ Ramos, J Battle: Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis. Thromb Haemostas 58:753-757, 1987.
8. Janson JH, TK Nilsson, O Johnson: Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 66:351-355, 1991.
9. Badimon L, JJ Badimon, JH Chesebro, V Fuster: Von Willebrand factor and cardiovascular disease. Thromb Haemostas 70:111-118, 1993.
10. Thompson SG, J Kienast, SDM Pyke, F Haverkate, JCW van de Loo: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635-641, 1995.
11. Van Genderen PJJ, IS Lucas, R van Strik, VD Vuzevski, FJ Prins, HHDM van Vliet, JJ Michiels: Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation. Thromb Haemostas 76:333-338, 1996.
12. Asada Y, A Sumiyoshi, T Hayashi, J Suzumiya, K Kaketani: Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38:469-479, 1985.
13. Moake JL: Haemolytic-uraemic syndrome: Basic science. Lancet 343:393-397, 1994.
14. Yosipovitch H, I Krause, D Blickstein: Erythromelalgia in a patient with thrombotic thrombocytopenic purpura. J Am Acad Dermatol 26:825-827, 1992.
15. Sanders WE, RL Reddick, TC Nichols, KM Brinkhous, MS Read: Thrombotic thrombocytopenia induced in dogs and pigs; the role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscl Thromb Vasc Biol 15:793-800, 1995.